A novel dual pH/redox-responsive polymeric nanoliposome system (NLs) loaded with a
copper-liganded bioactive complex was prepared and designed as a controlled delivery system for the management of
inflammation. The NLs were synthesised after preparation of the
copper-glyglycine-
prednisolone succinate] ([(Cu(glygly)(PS)]) complex, and the dual pH/redox responsive
biopolymer respectively. The methodology undertaken for the development of the drug delivery system involved coordination of the bioactive to
Copper (II), preparation of dual pH/redox responsive
biopolymer, and the synthesis of dual pH/redox nanoliposomes. Characterisations of the prepared
copper-liganded bioactive [
Copper-glyglycine-
prednisolone succinate] ([(Cu(glygly)(PS)]) complex, dual pH/redox responsive
biopolymer (
Eudragit E100-
cystamine) and [(Cu(glygly)(PS)]-loaded NLs were carried out using spectroscopic and physicochemical techniques. Results indicated a high inflammatory/
oxidant inhibitory activity of [Cu(glygly)(PS)] in comparison to the free PS drug. The [Cu(glygly)(PS)] complex exhibited a significant
free radical-scavenging activity (60.1±1.2%) and
lipoxygenase (LOX-5) inhibitory activity (36.6±1.3%) in comparison to PS which resulted in activity of 4.4±1.4% and inhibition of 6.1±2.6% respectively. The [Cu(glygly)(PS)] loaded NLs demonstrated low release profiles of 22.9±5.4% in 6h at pH 7.4, in comparison to a significant accelerated release at pH 5 in a reducing environment of 75.9±3.7% over 6h duration. Results suggest that the novel
copper-liganded bioactive delivery system with controlled drug release mechanism could serve as a potential drug delivery system candidate in the management of
inflammation.